Login to Your Account



Concert shares hit a high note on IPO debut

By Marie Powers
Staff Writer

Friday, February 14, 2014
Investors raised their wallets Thursday for Concert Pharmaceuticals Inc., which priced its initial public offering (IPO) at $14 – the top of its proposed range – after previously upsizing from 5 million to 6 million shares. The stock swelled above the offering price as trading commenced on the Nasdaq Global Market under the ticker “CNCE,” hitting $16.24 before settling back to close at $14.18 for a gain of 18 cents on the day.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription